13th BioAsia aims at Connecting the Dots in Life Sciences and Healthcare

Chandigarh, September 29, 2015: The Asia-Pacific biotechnology industry has been witnessing a growth phase on the back of several factors, such as cost effective manufacturing capabilities, improved clinical capabilities, growing health needs of large population base, exports and increasing government support among others. According to an industry report, the industry grew at the CAGR of 6.7 per cent between 2010-14 to reach a total of USD77 billion in 2014. India is witnessing a new era of growth and opportunities in the Life Sciences / Healthcare sectors and under this backdrop 13th edition of BioAsia (http://2016.bioasia.in/) – the widely attended annual international convention will be organized by the Industries & Commerce Department, Government of Telangana, Federation of Asian Biotech Associations and the Pharmaceutical Export Promotion Council, Government of India at Hyderabad International convention center – HICC, Hyderabad from February 8th to 10th, 2016. The theme for BioAsia 2016 will be - 'Leveraging India to succeed globally' with focus on connecting the dots to build stakeholder consensus and draw a distinct road-map to propel the growth in Indian Life Sciences sector.



With increasing pressure to reduce drug development costs and accelerate R&D programs, several MNCs have started setting up R&D centers in Asia to take advantage of cost-effective, yet highly skilled talent pool. India has emerged as a preferred destination for contract research and manufacturing activities, process reengineering and innovative R&D to act as a one stop solution with various enablers in place. The country is aided by a large, highly skilled community of scientists and researchers. Additionally, the government's support in bringing a comprehensive IPR Policy, launch of 'Make in India' and financial support programs, regulatory reforms, etc. are expected to further boost the growth for Life Sciences industry. BioAsia 2016 will aim to give additional impetus to this growth wave and will be a platform for Global thought leaders to brainstorm and debate on emerging trends in the industry and their perspectives on how to leverage potential and opportunities India is presenting to the global life sciences industry.



An expert committee constituted by the Government of Telangana, comprising of members from industry, academia, trade bodies, Secretary Industries Shri. Arvind Kumar IAS, Industries Commissioner and MD, TSIIC met recently in city to discuss the event plans.





BioAsia 2015 saw more than 500 companies from over 50 countries participate in this Global Biobusiness Forum and the 13th edition is only expected to be bigger and better with best names from the life sciences and pharma industry including corporates, global thought leaders, scientists, regulatory bodies and foreign delegates getting together in Hyderabad to be part of BioAsia 2016. Interested companies, institutions, academia and individuals can log on to http://2016.bioasia.in/registration_packages.htmlto register themselves for participating in the event.



About BioAsia: BioAsia is born with a vision to enhance, enrich and encourage newer innovations, path-breaking discoveries and effective solutions in the biotechnology industry by offering a vibrant global platform for convergence of the key stakeholders - Biotech & Biopharma Companies, research institutions, academia, investors, service providers, policy makers, regulators and analysts. BioAsia is focused in its efforts - to drive the growth of the industry by enabling an effective environment for fostering collaborations, JV's M&A's; ensure knowledge and experience sharing by global industry players to benefit all stakeholders; promote innovations and initiatives through appropriate awards and recognitions; play a pivotal role in advocating issues to the policy makers and chartering the road-map of bio-technology. BioAsia is a dynamic platform for companies -to exhibit, launch and showcase their unique strengths, products and services. BioAsia is playing the role of a key catalyst in mobilizing all elements that are required to drive the growth of the emerging industry of Biotechnology as well as optimize the immense business potential of biotech. On a larger level, BioAsia is working to drive a global transformation from the treatment of illness to wellness.



About FABA (Federation of Asian Biotech Associations):The Federation of Asian Biotech Associations [FABA], is a non-profit registered society engaged in various activities related to promoting Biotechnology in Asian countries. FABA, headquartered at Hyderabad made its humble beginning in 2004 and has achieved a significant landmark in creating a common platform for interaction among member countries and discuss the issues of common interest for improving the biotech space including Technology Transfer, resource sharing, business collaborations, Industry-Academia linkage, cross border trade and investments, etc. among its member countries., FABA has a strong network base in 20 Asian countries including China, India, Bangladesh, Malaysia, Philippines, Russia, Kazakhstan, Pakistan, Israel, Iran, Indonesia, Nepal, Japan, South Korea, Singapore, Thailand, Sri Lanka and UAE. Besides, FABA has entered into working understandings with Non-Asian organizations like European Federation of Biotechnology, Biocat (Spain), Maryland India Business Round Table (USA), Bio Industry Park (Italy) and Association of German Biotech companies (Germany), etc.



About Pharmexcil: Pharmexcil was set up by the Ministry of Commerce and Industry, Government of India in 2004 at Hyderabad for promotion of pharmaceutical exports from India. Various pharmaceutical products, namely, bulk drugs and its intermediates, formulations, biotech and biological products, herbal products, ayurvedic, unani and homeopathic medicines, diagnostics, surgical, neutraceuticals, collaborative research, contract manufacturing, clinical trials and consultancy, etc. are covered under its purview. Pharmexcil takes up several external trade promotion activities by organizing trade delegations outside India, arranging buyer-seller meetings, international seminars, interactive meetings on exports related issues, make suggestions to Govt. of India on policy issues relating to pharma exports, make representations to Govt. of India and other agencies in India and abroad to get amicable solutions for the common problems of the industry, etc.

Originally Source : Perfect Relations